Predicting lung nodule growth with CT scans
Part of Cancer, Lungs & breathing clinical trials.
This study uses artificial intelligence to analyze CT scans of lung nodules that look like ground glass, which may be early signs of cancer. The goal is to predict how these nodules will grow over time, helping doctors decide whether to monitor or treat them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a lung nodule that looks like ground glass on a CT scan, measuring 5 to 30 millimeters.
- Your CT scans are thin-slice (1.5 mm or thinner) and of good quality.
- You have had at least two CT scans taken more than one month apart.
- You have not had treatment for this nodule, such as surgery or radiation, before the study starts.
- You do not have other lung diseases that could interfere with the scans, and no other cancer in the chest or active cancer elsewhere in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new method to help tell whether a lung nodule is benign (non-cancerous) or malignant (cancerous). It is for people who already need a biopsy or surgery for their lung nodule.
This study uses artificial intelligence (AI) to help doctors analyze lung nodules seen on CT scans, with the goal of improving diagnosis and follow-up. It may help people who have a lung nodule that needs monitoring or clarification.
This study checks if artificial intelligence (AI) can accurately read CT scans of lung nodules (spots on the lung) to tell if they are cancer. Your participation helps improve diagnosis and may lead to better care.
This study uses CT scans and medical records to build a model that helps tell whether a solid lung nodule is benign (not cancer) or malignant (cancer). It aims to improve diagnosis and guide treatment decisions for people with these nodules.
This study tests whether an AI-based digital tool can help manage follow-up care for people with high-risk lung nodules (spots on the lung). It aims to improve monitoring and early detection of lung cancer.
This study uses special computer analysis of CT scan images to help tell whether lung nodules (small growths) are harmless (benign) or cancerous (malignant). The goal is to help doctors make better decisions about your care without needing more invasive tests.
Hear when a new Pulmonary Nodules trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.